In this approach, the enzyme carboxypeptidase G2 (CPG2) was genetically fused to the cyclic peptide CNGRC, which selectively binds to aminopeptidase N (APN)—a tumor-associated antigen overexpressed in various solid malignancies. This evidence concerns the gene SYNE1 and neoplasm.